Table 6 |
|
|
Known clinical outcomeof SAE cases reported to have occurred following ivermectin mass treatment from 1989 to 2001* |
|
| Clinical Outcome |
Frequency of occurrence (%) |
|
|
|
| Full recovery |
96 (70.1) |
| Full recovery (including neurologic) but other deficit persists |
4† (2.9) |
| Partial neurologic deficit |
9 (6.6) |
| Death |
28 (20.4) |
| Total |
137‡ (100) |
|
|
|
|
*cases reported as of August 31, 2002; †there were 2 cases of scarring due to drug skin reaction, 1 case of permanent soft tissue damage due to severe decubitus ulcers, and 1 case of nephrotic syndrome which predated the SAE; ‡the clinical outcome was not documented in 70 cases. |
|
|
Twum-Danso Filaria Journal 2003 2(Suppl 1):S3 doi:10.1186/1475-2883-2-S1-S3 |
|
